# Pregnancy-Related Cardiovascular Diseases: A Radiological Overview

## TL;DR

This paper reviews how imaging techniques like CT and MRI help diagnose heart diseases during pregnancy while minimizing risks to the fetus.

## Contribution

The paper outlines strategies to reduce radiation and contrast agent use in diagnosing pregnancy-related heart diseases.

## Key findings

- Cardiovascular imaging is essential for diagnosing pregnancy-related CVDs.
- Strategies following ALARA principles help reduce fetal exposure to radiation and contrast agents.

## Abstract

Pregnancy induces significant hemodynamic changes, and cardiovascular diseases (CVDs) are one of the leading causes of non-obstetric maternal morbidity and mortality during pregnancy or the postpartum period in developed countries. The effective diagnosis and management of CVDs in pregnant women require a thorough evaluation that considers the health of both the mother and the fetus. Imaging plays a pivotal role in this evaluation, offering essential insights into the most significant pregnancy-related CVDs. However, due to concerns about fetal exposure, the use of contrast agents and radiation exposure must be carefully managed. Following to the principle of “As Low As Reasonably Achievable” (ALARA), strategies to minimize these risks are crucial for ensuring patient safety while maintaining diagnostic accuracy. This review highlights the contribution of cardiovascular imaging techniques, particularly computed tomography (CT) and magnetic resonance imaging (MRI), in the assessment of common pregnancy-related CVDs, and outlines strategies to reduce radiation exposure and limit contrast agent use when feasible, aiming to increase radiologists’ awareness of this crucial topic.